1. Home
  2. GROW vs DARE Comparison

GROW vs DARE Comparison

Compare GROW & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Global Investors Inc.

GROW

U.S. Global Investors Inc.

N/A

Current Price

$2.97

Market Cap

32.7M

Sector

Finance

ML Signal

N/A

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$2.06

Market Cap

33.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROW
DARE
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
33.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
GROW
DARE
Price
$2.97
$2.06
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
30.5K
139.5K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
3.53%
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$23,850,609.00
$2,807,885.00
Revenue This Year
N/A
$2,115.12
Revenue Next Year
N/A
$122.62
P/E Ratio
$11.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.23
$1.27
52 Week High
$3.65
$9.19

Technical Indicators

Market Signals
Indicator
GROW
DARE
Relative Strength Index (RSI) 52.11 46.89
Support Level $2.88 $1.95
Resistance Level $3.26 $2.24
Average True Range (ATR) 0.10 0.12
MACD -0.03 0.01
Stochastic Oscillator 26.97 34.78

Price Performance

Historical Comparison
GROW
DARE

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: